Cibiyar Kula da Ciwon Kwayar Wuta

by Lynne Eldridge, MD; Binciken by Grant Hughes, MD

Mene ne Manufofin Cibiyar Kulawa da Ciwon Kwayar Wuta?

Kila ka ji labarin abokai da ƙaunataccen waɗanda suka kasance a kan maganin ciwon daji. Duk da haka, maganin rigakafi na rigakafin cutar daji ne kawai aka duba a kwanan nan. Yaya lokacin farfadowa da ake amfani dashi don ciwon huhu da kuma abin da ake nufi da wannan magani?

Mene ne Gidajen Kulawa?

Kafin fara magana game da magunguna da aka yi amfani dasu, yana taimakawa wajen ƙayyade ainihin abin da maganin kulawa yake.

Gidajen gyaran gyare-gyaren wani nau'i ne da ake amfani dashi tare da ciwon ciwon huhu na ciwon huhu - musamman, ci gaba da ciwon ciwon huhu na kananan kwayoyin halitta don ƙoƙarin inganta rayuwar, amma ba don maganin ciwon daji ba. Wannan ya bambanta da wasu jiyya ga ciwon daji na farko da cutar tajin da za a iya ba tare da magani a zuciya.

Ana iya amfani dashi a wasu lokatai ga mutanen da ke ciwon ciwon huhu na ƙananan ciwon daji (duba ƙasa.)

Magana mai sauƙi na farfadowa na ci gaba shine ci gaba da yin aiki na ciwon daji wanda bai ci gaba ba (ya kara tsanantawa) bayan an fara maganin ilimin chemotherapy - har sai akwai alamun cewa ciwon daji ya ci gaba (wahala.) A wasu kalmomi, magani ne da aka ba da ita. makasudin kiyaye ƙwayar da ba ta ci gaba da sauri ba a cikin bincike, ba magani wanda aka tsara don ragewa ko warkewarta ba.

Manufofin Cibiyar Kulawa

Tare da duk wani magani na ciwon daji da ka yi la'akari, yana da muhimmanci a yi tunani game da manufofin farfadowa.

Da wannan a hankali, yana da sauƙin yin la'akari da hadarin da ake yi akan maganin. Wadannan manufofi na farko guda hudu ne:

Mai kariya
Curative
Gudanarwa management
Palliative

Ana amfani da farfadowa na kulawa don kula da cutar. Ba magani ba ne, duk da haka yana "aikatawa" fiye da maganin farfadowa da cewa an tsara shi don yin fiye da taimakon bayyanar cututtuka kawai - burin shi shine fadada rayuwa da ingancin rayuwa a lokacin rayuwa.

Yaushe Ana Amfani?

Don ayyana magunguna don ciwon ciwon huhu na ciwon huhu, yana amfani da magungunan bayan an ba mutum wani nau'i hudu na "chemotherapy" na farko (mataki IIIA da mataki na IV) cutar kanjamau idan ciwon daji bai ci gaba ba a wannan lokacin -line magani. Ganin cewa a baya, mutane ba a kula da su ba a wannan lokaci (kuma a maimakon haka ana bin wannan lokacin " jiran jiragen " - wato, kula da bayyanar cututtuka da nazarin rediyo don gane ko ciwon daji zai yi girma), an tsara aikin farji don taimakawa tare da bayyanar cututtuka na ciwon daji, kuma, da fatan za su inganta zaman rayuwa fiye da abin da samuwa ta farko keyi.

Akwai matsaloli masu yawa kewaye da amfani da farfadowa. Kamar yadda yake tare da wani magani, dole ne a auna nauyin farfadowa na jiyya akan kowane amfani. Kuma - a cikin tattalin arzikinmu na yanzu - farashin ma la'akari ne. Magunguna da aka tsara domin "kiyayewa" na iya zama tsada sosai. Wasu nazarin na nuna kawai ƙaramin cigaba a rayuwar (wani lokaci na mako zuwa mafi yawan), kuma ana barin sauran iyalai tare da yin la'akari da sauƙin inganta rayuwa tare da nauyin kudi na magani.

Menene Magunguna Ana Amfani?

A halin yanzu, akwai maganin likita biyu da FDA ta amince don maganin farfadowa don ciwon daji na ciwon huhu.

Wasu magunguna da dama (da kuma haɗin magunguna) ana nazarin su a gwaji . Masanan sun hada da:

Alimta (sanadiyar) - A shekara ta 2009, FDA ta yarda da amfani da Alimta don maganin ciwon daji na huhu.
Tarceva (erlotinib) - FDA ta amince da Tarbava don amfani da maganin cutar kanjamau a shekara ta 2010.

Wanene Ya Amfana Mafi Yawancin?

Kamar yadda mafi yawan maganin jijiyar cutar huhu, akwai wasu mutane da suka fi dacewa da sauran su zuwa farfadowa.

Nazarin da Alimta sun nuna cewa zai zama mafi tasiri ga mutanen da ke fama da ciwon huhu da kuma ciwon huhu na tsofaffin mahaifa. Har ila yau, zai zama mafi tasiri a cikin mutanen da suke da maye gurbin EGFR .

Nazarin tare da Tarceva kuma ya nuna inganta rayuwar da farko ga mutanen da ba su da kananan kwayoyin cutar kanjamau wanda ba kwayar cutar kanjamau ba. Har ila yau, yana amfana da amfana da mutane da maye gurbin EGFR zuwa matsayi mafi girma fiye da waɗanda ba su da maye gurbin. An samo mafi amfani da lafiyar rayuwa da Tarceva tare da matan da ba su taba shan taba ba, wadanda ke cikin lafiyar lafiya duk da haka a lokacin magani.

Hanyoyin da ke tattare da gefuna da matsalolin

Tsarin Kula da Ƙwayar Ciwon Kwayar Ciwon Kwayar Kwayoyin Kwayoyin Kwayoyin Ciki

Yayin da ake amfani da farfadowa na maganin rigakafin cutar kanjamau, jarrabawar gwaji a cikin kwanan nan ya nuna cewa zai iya zama muhimmiyar rawa a cikin babban ciwon ƙwayar cutar ciwon huhu na kananan ƙwayoyin cuta , tare da tasowa ga inganta rayuwar da aka gani tsakanin mutanen da ke biye tare da gyare-gyare na gyare-gyare tare da cranial prophylactic irradiation.

Taimako da Kwafi

An ce an gano cewa daya daga cikin "farfadowa masu illa" na farfadowa na tabbatarwa shi ne cewa mutane ba su da mahimmancin jiyya. A wasu kalmomi, basu jin kamar "tsira" ba. Zai iya taimakawa wajen tunawa da cewa magani na hormonal don maganin jijiyar nono yana dauke da farfadowa da magunguna, kuma mafi yawan mutanen da suka ci ciwon nono na ci gaba da ɗaukar maganin hormonal, ko dai tamoxifen ko mai cin zarafin aromatase idan sun gama maganin ciwon daji. . Yana iya taimakawa wajen tunatar da mu duka game da ma'anar wanda ya tsira daga ciwon daji: wani mai ciwon daji ne daga lokacin da aka gano su da cutar, da sauran rayuwarsu.

Zai yiwu cewa tare da ciwon rigakafi na ciwon daji na ƙwayar cuta zai kara yawan mutane da amfani da wannan magani da kuma muhimmancinta. Manufar ita ce cewa muna fara maganin ciwon daji a cikin mahaifa kuma yafi kamuwa da cuta mai tsanani . Ba za mu iya warkar da mutane mafi yawa ba, amma cutar za ta iya kasancewa mai kulawa don karin lokaci.

_Sources:

_{Ahn, M. et al.} _{Amfanin Kulawa da Magungunan Pharmacotherapies na Kwayoyin Ciwon Kwayoyin Ƙwayar Cikin Kwayoyin Cutar.} _{Ƙwararren Ƙwararrun Ƙwararru.} _{Oncology .} _{2012. 6: 253-262.}

_{Ƙasar Amirka ta Cibiyar Nazarin Harkokin Kwayoyi.} _Cancer.Net. _{Fahimtar Farfesa.} _{Updated 08/15.} _{http://www.cancer.net/navigating-cancer-care/how-cancer-treated/understanding-maintenance-therapy}

_{Banz, K. et al.} _{Daidaita farashin maganin saiti 3/4 abubuwa masu ban sha'awa da ke hade da erlotinib ko maganin magance cututtuka ga marasa lafiya da ciwon daji marasa ciwon daji (NSCLC) a Jamus, Faransa, Italiya, da Spain.} _{Lung Cancer .} _{2011 Mayu 16. (Epub gaba da bugu).}

_{Brugger, W. et al.} _{Ƙarin binciken da aka yi da nau'i na ma'auni na EGFR da KRAS Daga binciken Randomized, Nazarin Controlbo na Erlotinib Cibiyar Kulawa da Ciwon Kwayoyin Ciwon Kwayoyin Ciwon Kwayoyin Kwayoyin cuta.} _{Journal of Clinical Oncology .} _{2011 Oktoba 3. (Epub gaba da bugu).}

_{Cappuzzo, F. et al.} _{Erlotinib a matsayin maganin kulawa a cikin ciwon daji marasa ciwon tsofaffin kwayar cutar ciwon huhu: wani bincike mai yawa, bazuwar wuri, mai gudanarwa na wuribo-lokaci 3.} _{Lancet Oncology .} _{2010. 11 (6): 521-9.}

_{Chen, X., Liu, Y., Roe, O. et al.} _{Gefitinib ko erlotinib a matsayin magungunan maganin marasa lafiya tare da ci gaba da ciwon daji marasa ciwon kwayar cutar ciwon huhu: nazari na yau da kullum.} _{PLoS Daya .} _{2013. 8 (3): e5934.}

_{Ciuleanu, T. et al.} _{Gudanar da gyare-gyare tare da kulawa mafi kyau da wuribo tare da kulawa mafi kyau ga marasa ciwon huhu na ƙananan ciwon ƙwayar cuta: ƙwararriyar makafi, makafi biyu, nazarin zamani 3.} _{Lancet .} _{2009. 374 (9699): 1432-40.}

_{Cohen, M. et al.} _{Bayanin amincewa: gyaran gyare-gyaren gyare-gyare na ciwon ƙwayar cutar ciwon daji (NSCLC).} _{Oncologist .} _{2010. 15 (12): 1344-51.}

_{Cohen, M. et al.} _{Bayanin amincewa: maganin kulawa na ci gaba / cike da ƙananan ƙwayoyin cuta, ƙananan ƙwayar cutar ciwon huhu (NSCLC).} _{Oncologist .} _{2010. 15 (12): 1352-8.}

_{Coudert, B. et al.} _{Amfani da ciwon daji tare da maganin ci gaba na marasa lafiya a cikin marasa lafiya tare da ciwon daji marasa ciwon kwayar cutar kanjamau (NSCLC) bisa ga mayar da martani ga na farko na chemotherapy.} _{Annals na Oncology .} _{2011 Mayu 24. (Epub gaba da bugu).}

_{Dickson, R. et al.} _{Erlotinib Monotherapy don Kula da Ciwon Kwayoyin marasa lafiya da ƙananan ciwon ƙwayar cutar a baya bayanan da ke ci gaba da maganin kwarewa: A NICE Single Technology Appraisal.} _{Pharmacoeconomics .} _{2011 Oktoba 3. (Epub gaba da bugu).}

_{Greenhalgh, J. et al.} _{An yi amfani da shi don tabbatar da maganin ci gaba da ciwon ƙwayar cutar ciwon ƙwayar ƙwayar jiki ko ƙwayar cuta.} _{Rahoton Kiwon Lafiya .} _{2010. (Fit 2): 33-9.}

_{Jiang, Y., Liu, L., Shen, L. et al.} _{Magungunan gargajiya na gargajiya na kasar Sin a matsayin maganin cigaba a cikin ciwon daji marasa ciwon ƙwayar cutar ƙwayar cutar ta jiki: Jarabawar gwajin da aka samu.} _{Ƙarin Magunguna a Magunguna .} _{2016. 24: 55-6.}

_{Han, Y., Wang, H., Xu, W. et al.} _{Magungunan maganin gargajiyar kasar Sin a matsayin magunguna don inganta rayuwar rayuwar marasa lafiyar kananan marasa lafiya na celllung.} _{Ƙarin Magunguna a Magunguna .} _{2016. 24: 81-9.}

_{Hu, X., Pu, K., Feng, X. et al.} _{Matsayi na Gemcitabine da Pemetrexed a matsayin Maintenance Far a Advanced NSCLC: A Review System da Meta-Analysis na Randomized Controlled gwaji.} _{PLoS Daya .} _{2016 8:11 (3): e0149247.}

_{Karayama, M., Inui, N., Fujisawa, T. et al.} _{Tsarin farfadowa tare da maganin ƙwaƙwalwa da ƙwaƙwalwar ƙwayar ƙwayoyin cuta bayan ƙaddamar da ƙwayar cuta tare da carboplatin, pemetrexed, da kuma bevacizumab a cikin marasa lafiya tare da ciwon ciwon huhu na ƙananan ƙwayoyin marasa ci gaba.} _{Jaridar Turai na Ciwon daji .} _{2016 Feb 25. (Epub gaba da bugu).}

_{Klein, R. et al.} _{Ƙimar tasiri mai kyau a matsayin maganin na farko da na farko don maganin ciwon daji na ƙananan ƙwayar cutar kwayar cutar.} _{Jaridar Thoracic Oncology .} _{2010. 5 (8): 1263-72.}

_{Kulkarni, S., Vella, E., Coakley, N. et al.} _{Yin Amfani da Jiyya a Hanyar Kula da marasa lafiya tare da marasa ciwon ƙwayar cutar ƙwayar cutar ƙwayar cuta: A Review System.} _{Jaridar Thoracic Oncology .} _{2016 Mar 21. (Epub gaba da bugu).}

_{Lu, S., Yu, Y., Chen, Z. et al.} _{Tsarin Noma Ya inganta Sakamakon Nasarawa a Ciwon Maraba da Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙwayar Ciwon Kwayoyin Ƙwayar cuta: Meta-Analysis na Nazarin 14.} _{Lung .} _{193 (5): 805-14.}

_{Muir, V., da kuma S. Chillon.} _{Erlotinib: kamar yadda kulawa da ƙwayar cuta a cikin marasa ciwon ƙwayar cutar kanjamau.} _{BioDrugs .} _{2011. 25 (3): 139-46.}

_{Petrelli, F. et al.} _{Erlotinib a matsayin magungunan maganin marasa lafiya tare da ciwon daji marasa ciwon ƙwayar cutar ciwon daji: wani bincike na musamman na gwaji guda uku.} _{Anticancer Drugs .} _{2011. 22 (10): 1010-9.}

_{Pinquie, F., de Chabot, G., Urban, T., da J. Hureaux.} _{Maintanance Jiyya by Eroltinib wani Toxic Cardiomyopathy: A Case Report.} _{Oncology .} _{2016. 90 (3): 176-7.}

_{Qi, W. et al.} _{Erlotinib da kuma magance shi a matsayin maganin ci gaba don ci gaba da ciwon daji na ƙananan ƙwayar cutar kwayar cutar.} _{Binciken Lafiya na Yanzu da Rahoto .} _{2012 Mar 14. (Epub gaba da buga).}

_{Rodriguez, P., Popa, X., Martinez, O. et al.} _. _{Ciwon Binciken Ciwon Bidiyo .} _{2016 Feb 29. (Epub gaba da bugu).}

_{Salama, J., Gu, L., Wang, X. et al.} _{Kyakkyawan haɗaka tsakanin Tsarin Gyaran Cranial da Kula da Kwayoyin Tsarin Kwayoyin Tsarin Kwafi A Matsayin Kwararrun Kwararrun Ciwon Kwayoyin Ciwon Kwayoyin Kwayoyin Tsarin Kwayoyin cuta Bayan Kwararrun Kwayoyin Kwayoyin Halitta: Nazari na Biyu na CALGB 30504 (KASHI).} _{Jaridar Thoracic Oncology .} _{2016. 11 (3): 361 = 9.}

_{Schneider, B. Tsarin maganin rigakafi don ƙwayar cutar ciwon huhu na kananan ƙwayar cuta: sabon saiti, wani zaɓi ko mataki a hanya mai kyau?} _. _{Translation na Lung Cancer Research .} _{2015. 4 (5): 6358.}

_{Makiyayi, F. Tsarin Ciwon Noma Yaya Shekaru ga Ƙwararren Ciwon Kwayoyin Cizon Ƙananan Ciki, amma a Menene Kudin?} _. _{Journal of Clinical Oncology .} _{2011 Oktoba 3. (Epub gaba da bugu).}

Mene ne Gidajen Kulawa?

Manufofin Cibiyar Kulawa

Yaushe Ana Amfani?

Menene Magunguna Ana Amfani?

Wanene Ya Amfana Mafi Yawancin?

Hanyoyin da ke tattare da gefuna da matsalolin

Related Content

Fresh articles

Intresting articles